Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics-Reference-Cited by-同舟云学术

Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics

Published:2018-01-10 Issue:3 Volume:23 Page:295-305
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Smolders E. J.¹,Thammajaruk N.²,de Kanter C. T. M. M.³,Colbers A.¹,Chaiyahong P.²,Cuprasitrut T.²,Chittmittraprap S.²⁴,Apornpong T.²,Khemnark S.⁵,Tangkijvanich P.⁴,Burger D. M.¹,Avihingsanon A.²⁶,

Affiliation:

1. Department of Pharmacy & Radboud Institute for Health Sciences; Radboud University Medical Center; Nijmegen The Netherlands

2. HIV-Netherlands Australia Thailand Research Collaboration; Thai Red Cross AIDS Research Centre; Bangkok Thailand

3. Department of Pharmacy; University Medical Center Utrecht; Utrecht The Netherlands

4. Department of Biochemistry; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand

5. Department of Medicine; Bamrasnaradura Institute; Nonthaburi Thailand

6. Department of Medicine; Faculty of Medicine; Chulalongkorn University; Bangkok Thailand

Funder

National Health Security Office (NHSO), Bangkok, Thailand

The Aligning Care and Prevention of HIV/AIDS with Government Decentralization to Achieve Coverage and Impact: ACHIEVED Project (The Global fund Project, Thailand)

Government Budget/Medical Research Network

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tmi.13027/fullpdf

Reference29 articles.

1. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis;Platt;Lancet Infect Dis,2016

2. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort;Law;AIDS,2004

3. Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 national survey;Wasitthankasem;PLoS ONE,2016

4. Treatment of hepatitis C;Kim;Am J Med,2005

5. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3;Tapper;J Viral Hepat,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel recyclable nano-adsorbent for enhanced oil recovery with efficient removal of Ca2+ and Cr6+ from oilfield wastewater;Korean Journal of Chemical Engineering;2022-07-06

2. Interferon-α2b induced anemia in severe coronavirus disease 2019 patients: a single centered, retrospective study;Immunopharmacology and Immunotoxicology;2021-10-26

3. Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis;PLOS ONE;2021-05-20

4. Assessment of the Potential Adverse Events Related to Ribavirin-Interferon Combination for Novel Coronavirus Therapy;Computational and Mathematical Methods in Medicine;2020-09-24

5. Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA Genotype;Therapeutic Drug Monitoring;2019-08